Phio Pharmaceuticals Corp Stock Market Value
| PHIO Stock | USD 2.53 0.15 6.30% |
| Symbol | Phio |
Phio Pharmaceuticals Corp Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.81) | Return On Assets (0.61) | Return On Equity (1.27) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Phio Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Phio Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Phio Pharmaceuticals.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Phio Pharmaceuticals on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Phio Pharmaceuticals Corp or generate 0.0% return on investment in Phio Pharmaceuticals over 30 days. Phio Pharmaceuticals is related to or competes with Zura Bio, Immix Biopharma, Cns Pharmaceuticals, ZyVersa Therapeutics, Ocean Biomedical, Elevation Oncology, and Sonnet Biotherapeutics. Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States More
Phio Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Phio Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Phio Pharmaceuticals Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 36.22 | |||
| Value At Risk | (10.38) | |||
| Potential Upside | 11.78 |
Phio Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Phio Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Phio Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Phio Pharmaceuticals historical prices to predict the future Phio Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | (0.18) |
Phio Pharmaceuticals Corp Backtested Returns
Phio Pharmaceuticals Corp maintains Sharpe Ratio (i.e., Efficiency) of -0.0252, which implies the firm had a -0.0252% return per unit of risk over the last 3 months. Phio Pharmaceuticals Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Phio Pharmaceuticals' Risk Adjusted Performance of (0.01), variance of 39.64, and Coefficient Of Variation of (3,238) to confirm the risk estimate we provide. The company holds a Beta of 1.13, which implies a somewhat significant risk relative to the market. Phio Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Phio Pharmaceuticals is expected to follow. At this point, Phio Pharmaceuticals Corp has a negative expected return of -0.16%. Please make sure to check Phio Pharmaceuticals' value at risk, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Phio Pharmaceuticals Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.51 |
Good reverse predictability
Phio Pharmaceuticals Corp has good reverse predictability. Overlapping area represents the amount of predictability between Phio Pharmaceuticals time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Phio Pharmaceuticals Corp price movement. The serial correlation of -0.51 indicates that about 51.0% of current Phio Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.51 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Phio Pharmaceuticals Corp lagged returns against current returns
Autocorrelation, which is Phio Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Phio Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Phio Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Phio Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Phio Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Phio Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Phio Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Phio Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Phio Pharmaceuticals Lagged Returns
When evaluating Phio Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Phio Pharmaceuticals stock have on its future price. Phio Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Phio Pharmaceuticals autocorrelation shows the relationship between Phio Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Phio Pharmaceuticals Corp.
Regressed Prices |
| Timeline |
Pair Trading with Phio Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Phio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Phio Stock
The ability to find closely correlated positions to Phio Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Phio Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Phio Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Phio Pharmaceuticals Corp to buy it.
The correlation of Phio Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Phio Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Phio Pharmaceuticals Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Phio Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Phio Pharmaceuticals Correlation, Phio Pharmaceuticals Volatility and Phio Pharmaceuticals Alpha and Beta module to complement your research on Phio Pharmaceuticals. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Phio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.